Angiotensin Receptor Blockers (ARBs) Market 2023 : Trends, Business Growth And Major Driving Factors | Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GSK Plc

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Angiotensin Receptor Blockers (ARBs) Market Size, Growth Rate, And Forecast
The global angiotensin receptor blockers (ARBs) market size is expected to grow from $8.02 billion in 2022 to $8.30 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global angiotensin receptor blockers (ARBs) market size is expected to grow to $9.40 billion in 2027 at a CAGR of 3.2%.

Get A Free Sample Report Link
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp

Angiotensin Receptor Blockers (ARBs) Market Drivers
The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. By assisting in vein and artery relaxation, angiotensin receptor blockers lower blood pressure and facilitate the heart's ability to pump blood, which can reduce cardiovascular diseases.

Learn More On The Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report

Angiotensin Receptor Blockers (ARBs) Market Segments
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Angiotensin Receptor Blockers (ARBs) market.

Check Out Buying Options For The Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943

Angiotensin Receptor Blockers (ARBs) Market Key Players
Major players in the angiotensin receptor blockers (arbs) market are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GSK Plc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co. Ltd., Lupin Pharmaceuticals Inc., Astellas Pharma Inc., and Boehringer Ingelheim Ltd.

The Business Research Company's "Global Angiotensin Receptor Blockers (ARBs) Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table Of Content For The Angiotensin Receptor Blockers (ARBs) Market Include:
1. Executive Summary
2. Angiotensin Receptor Blockers (ARBs) Market Characteristics
3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies
4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario
5. Angiotensin Receptor Blockers (ARBs) Market Size And Growth
……
27. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market
29. Angiotensin Receptor Blockers (ARBs) Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.